6 Reasons to Incorporate Low Level Laser Therapy into your Practice

• Numerous treatment capabilities from Low Level Laser Therapy (LLLT) include treatment of: arthritis, tendon and ligament problems, nerve root irritation, neck, shoulder and back pain, repetitive stress injuries, TMJ, plantar fascitis, burns, wounds, acne, skin conditions, acupuncture and trigger points, addiction treatments & more. LLLT causes certain photochemical reactions to occur to help control pain, reduce inflammation, and accelerate healing of damaged tissue.
• Fast, efficient and painless treatment: Low level laser therapy is painless and gives great clinical results with a minimum time involvement. Low level laser therapy will increase your patient compliance and satisfaction through efficient and highly effective treatment.
• You will grow your practice by providing additional proven pain management, injury and wound care rehabilitation to your existing patient base. Many patients have claimed that the laser is what made the difference in accelerating their healing and getting them well. You will find that many returning patients specifically request to have laser therapy.
• You will attract new patients, which will seek your care due to the need for therapeutic laser rehabilitation treatments. Referrals will come in from medical doctors, healthcare practitioners and coaches who know you use low-level laser therapy.
• Set your clinic apart from the competition by providing the most modern form of therapeutic technology.
• Increase profitability of your practice though more treatment options & additional billable services.

Theralase Technologies Inc. (TSXV : TLT) designs, develops and manufactures patented, super-pulsed laser technology used in a wide range of bio-stimulation and bio-destruction clinical applications. The Theralase technology platform targets several diverse healthcare sectors firstly, for non-invasive pain management and clinical therapy, in hundreds of neural muscular skeletal conditions, (including arthritis) secondly, to bio-stimulate and accelerate wound care and healing, (including; bone fracture regeneration and osteoarthritic conditions) and thirdly, combining photodynamic compounds with super-pulsed, biofeedback laser technology to attack specifically targeted cancers, bacterium, viruses and fat cells.
Contact us at 1-866-843-5273 www.theralase.com 

Survey of Profession Finds That Laser Care Increases Revenues http://ping.fm/iId1E

Survey of Profession Finds That Laser Care Increases Revenues

An impressive 92% of DCs who use laser care would recommend other DCs add therapeutic lasers to their practice, a Dynamic Chiropractic email survey has found. Not surprisingly perhaps, 75% of those who would recommend it to peers said it is because these devices have proven to be a very effective part of their treatment strategy, while 45% said their patients enjoy laser care and have referred others as a result of the laser care.

As Dr. Todd Austin of Illinois remarked: "Our clinic's low level lasers improve ROM, decrease inflammation and edema, help to increase oxygenation of the damages target issues, speed up the healing process and (even more importantly in my opinion) increase the damaged tissue's ability to handle additional stress. The bottom line is: if there are damaged cells or tissues present, LLLT (low-level laser therapy) will usually be of benefit."

Equally impressive are the business results our respondents reported: Forty percent said they have seen an increase in practice income as a result of incorporating laser therapy into their treatments. Another 26% reported that the reputation of their practice has improved.

Who Uses Lasers and How

Approximately a third of DCs utilize laser care on half or more of their patients. When asked about the patient complaints they had the most success addressing with laser care treatment, they responded:

• Extremity Pain - 77%
• Neck & Shoulder Pain - 72%
• Back Pain - 60%
• TMJ Disorders - 41%
• Disc Herniation - 29%
• Disc Herniation with Radiculopathy - 27%

Laser care fits well into the chiropractic philosophy with 94% of DC users totally or somewhat agreeing that they "believe in the philosophy of laser care."

One doctor who took the survey noted: "Overall, I find it a very effective therapy when used alone and works excellently with Chiropractic adjustments." Stephen Fedele, Jr., DC, of California agrees: "It speeds recovery and shows that they can recover without drugs and surgery."

Quality is not an issue as 90% totally or somewhat agreed that they are "confident in the quality of my laser." And while price can always be a challenge, just under 60% agreed (totally or somewhat) that their laser was "very affordable." Dr. Stephen M. Savoie of Florida said laser therapy "is an extremely effective modality that provides pain relief and recovery with less effort on the doctor's part at an affordable price."

Why Not Use Lasers?

So why don't more doctors of chiropractic use lasers in their practice? The answer appears may be a lack of information.

Only 45% of DC users totally agreed that they were ready to use their laser based upon the "information provided with my laser." Many DCs gained additional information before and after they made their purchase from a number of sources (see accompanying graphic).

This same theme is echoed by doctors who don't current own lasers, but are considering making a purchase. Less than half are "very" or "somewhat" confident in their "understanding of lasers and their application in your practice."

When asked what additional information would assist them in making their decision, doctors who considering purchasing a laser device for their practice stated overwhelmingly preferred they wanted in writing or from attending seminars and webinars.

Laser Preferences

One of the more interesting data points to emerge from this survey was the apparent lack of differentiation between "high level" lasers (Class IV/above 500 milliwatts) and "low level" lasers (Class III/below 500 milliwatts). When asked which type of laser these doctors are considering to purchase, 54% stated "either." This may also suggest that doctors believe that both are equally effective.

Lasers are clearly seen as a valuable clinical tool by those DCs who are currently using them in their practice. They are seen as an effective adjunct to the adjustment, fitting both philosophically and financially. In addition they increase both income and referrals for almost half of the DCs who use them. According to William J. Kneebone, DC, of California "Therapeutic laser provides the most rapid and predictable relief of any modality that I've used in my 32 years of practice.

Those doctors thinking about adding lasers to their care should spend a good amount of time learning about how lasers work and what specific products are available. DCs will want to be confident that they are purchasing the right therapeutic laser for their practice.

Toronto Blue Jays Use Theralase Laser Technology http://www.theralase.com/brochures/Blue%20Jays%20ad%20(Apr%20-%20June).pdf

Toronto Blue Jays Use Theralase Laser Technology

"The Toronto Blue Jays use Theralase Theralase is without a doubt, the most effective therapeutic laser technology we have ever used. Our players love it, our team loves it". said Toronto Blue Jays Head Trainer George Poulis. check out http://bit.ly/m9Fdnx

Cold Laser Therapy: Theory and Clinical Applications Seminar

Presented by Canadian Memorial Chiropractic College Division of Continuing Education and TheraLase Technologies Inc 

Credit Hours: 6

Speakers:
Michael Bilas, BSc P.T.
Martin Lapointe, DC

Date & Time:
Saturday, June 4, 2011 (9:00 a.m. - 4:00 p.m.)

Location: 
Le Nouvel Hotel & Spa
1740 boul. René-Lévesque Ouest
Montréal, QC

This one day lecture and hands on workshop will focus on the use of laser therapy in a clinical practice. It will also provide participants the material and theories on how lasers work, the effects of laser on living tissue, and the use of lasers in treating specific neuromuscular conditions.

Program Objectives

• Understand how laser light affects tissues and healing
• Identify musculoskeletal injury types that are indicated for primary or adjunctive laser treatment
• Design clinical laser treatment programs, including frequency of treatments, duration of care, and targeting for musculoskeletal injuries
• Select optimal laser dosage, including power and time settings, to treat a variety of musculoskeletal conditions in a clinical setting.
• Operate a laser safely, including treatment room design and patient and technician procedures
• Differentiate laser equipment through the comparison of key technology parameters

Theralase Technologies Inc. Announces its Year End Financial Results http://ping.fm/3zQcM

Theralase Technologies Inc. Announces its Year End Financial Results

Company Primed for Growth - Exciting Progress in Research and Development

Toronto, Ontario – May 2, 2011 (Marketwire Canada) Theralase Technologies Inc. (TSX‐V: TLT) announces its year end 2010 financial results.

Total revenue for twelve months ending December 31, 2010 at $2,040,537 compared to $2,359,855 for the same period in 2009.

Selling expenses increased by 39%, to $662,064 for the twelve month period ending December 31, 2010 compared to $476,416 for the same period in 2009. The percentage increase is due to increased spending on travel and advertising. 

A 26% increase in administrative expenses ($1,255,572 for twelve months ending December 31, 2010 compared to $992,742 for the same period in 2009) represents increased expenditures on stock‐based compensations and salaries (recent hires – sales, production and accounting).

Roger Dumoulin‐White, President and CEO of Theralase Technologies Inc. stated, “The net loss for the period ended December, 2010 was $1,199,725, which included $303,610 of non‐cash expenses (amortization, stock‐based compensation expense, and foreign exchange gain/loss and lease inducements). Research and development expenses increased by 334% from $164,184 in 2009 to $547,987 in 2010. The company expenses the future product development costs of the TLC‐2000 Biofeedback Therapeutic Laser and TLC‐3000 Photo Dynamic Compound Cancer Destruction Technology from existing TLC‐1000 therapeutic laser product sales, resulting in the overall net loss.”

Mr. Dumoulin-White added, “The Company is poised for significant growth in the 2nd half of 2011 as the Company expands its sales and marketing efforts in Canada, the US and internationally with the addition of qualified sales professionals, including the launch of an experienced equine sales team. As well, the Company is preparing for the unveiling of its patented TLC‐2000 Biofeedback Therapeutic Laser in 4Q2011. On the research front, exciting progress is being made in the destruction of cancer cells utilizing Theralase’s patented Photo Dynamic Compounds (PDCs) as well as in bacteria destruction. In order to capitalize on this research, we are considering entering into joint venture arrangements and/or strategic alliances.”

Subsequent to the Company’s year-end, Theralase completed an oversubscribed private placement on January 7, 2011 for gross proceeds of $737,500.

The complete consolidated financial statements and MD&A for twelve months ending December 31, 2010 can be found at www.theralase.com and www.sedar.com.

About Theralase Technologies Inc.

Theralase Technologies Inc. designs, develops and manufactures patented, super-pulsed laser technology utilized in bio-stimulation and bio-destruction applications in the United States, Canada and internationally. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. These applications extend to the care of animals by veterinarians. When combined with patented light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria and viruses.

This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

Theralase Technologies Inc.

Roger Dumoulin - White,                                                                                    Greg Bewsh

President & CEO                                                                                                  Director of Investor Relations

416-447-8455 ext. 225                                                                                      416-447-8455 ext. 262

rwhite@theralase.com                                                                                       gbewsh@theralase.com 

www.theralase.com

Theralase Offers Free Cold Laser Treatments at Sporting Life’s 10K Run http://ping.fm/kZLT2

Theralase Offers Free Cold Laser Treatments at Sporting Life’s 10K Run in Support of Children with Cancer

Theralase had a successful day at Sporting Life’s 10K Run in support of children with cancer held Sunday, May 1st. At the finish area runners with aches and pains were offered a free Cold Laser Therapy Treatment. Most of the runners confirmed that they felt much better and appreciated Theralase’s participation in the event. Theralase will be present at most major charitable running events this summer in the Toronto area to offer some pain relief for the participants and have the opportunity to explain Theralase’s patented technology.